Brad Spellberg is an Infectious Disease physician affiliated with University of Southern California. OpenAlex indexes 354 publications with 33,511 citations (h-index 80); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Infectious Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1000 W Carson St
Box 480
Torrance, CA 905022004
Telephone
310-222-3813Registry record last updated 8 Jul 2007.
Clinical trials
- The Bed Rest Avoidance Study
Sponsor: University of Southern California
- The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study
Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AngioDynamics, Inc.Program year20251 payment
- GlaxoSmithKline, LLC.Program year20211 payment
- Celltrion, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
13 NIH research awards on record, funded 2004–2026 per NIH RePORTER. The latest:
- Characterizing trained innate immunity mediated by AMMO
University of Southern California
FY2026$835,021R01AI198971 - MAb Passive Vaccination against Acinetobacter baumannii
University of Southern California
FY2024$788,308R01AI130060 - MAb Passive Vaccination against Acinetobacter baumannii
University of Southern California
FY2023$788,017R01AI130060
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Oral Is the New IV. Challenging Decades of Blood and Bone Infection Dogma: A Systematic Review
The American Journal of Medicine
2021 - Defining the Breakpoint Duration of <i>Staphylococcus aureus</i> Bacteremia Predictive of Poor Outcomes
Clinical Infectious Diseases
2019 - Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
Clinical Microbiology Reviews
2017
Similar KOLs
Other experts from the same institution or the same specialty.
David Liebeskind, MD
University of Southern California
Lon Schneider, MD
University of Southern California
Amytis Towfighi, MD
University of Southern California
Norah Terrault, MD
University of Southern California
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”